Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04269525 |
|
Recruitment Status :
Recruiting
First Posted : February 13, 2020
Last Update Posted : July 1, 2020
|
Sponsor:
ZhiYong Peng
Collaborator:
Tuohua Biological Technology Co. Ltd
Information provided by (Responsible Party):
ZhiYong Peng, Zhongnan Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 1, 2020 |
| Estimated Study Completion Date : | December 30, 2020 |